NASDAQ | TSX: ACBCanada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for PatientsEDMONTON, AB, March 4, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced today the availability of medical cannabis pastilles for doctors to prescr ...

 NASDAQ | TSX: ACB EDMONTON, AB, Feb. 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today announced that it has repaid an aggregate of approximately $7.2 million (US$5.3 million), representing the final payment on the principal amount of its convertible senior notes ("Notes") at a total cash cost of $7.4 million (~US$5.5 million), including accrued interest. Following the completion of this repayme ...

合作宣布 - Aurora Cannabis Inc.宣布与Script Assist合作，为英国患者提供高质量医疗大麻产品和信息指导[1] 产品提供 - Script Assist平台将提供Aurora的多款医疗大麻产品，包括来自加拿大EU GMP设施的新产品[2] 便捷流程 - Script Assist推出了“找医生”应用，方便患者与专科处方医生联系，实现医疗大麻处方的便捷流程[4]

Aleksandr_Kravtsov/iStock via Getty Images Aurora Cannabis (NASDAQ:ACB, ACB:CA) recently completed the consolidation of common shares on a 10:1 basis to maintain its minimum bid requirement to stay on the NASDAQ. This is the second time the company has done a reverse share split, with the first being back on May 11, 2020 on a 12:1 basis. StockCharts I previously suggested the company may turn around in 2023 and I may have been too early. But as absolutely bleak as the stock price chart looks there see ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Marijuana Stocks To Buy Before March BeginsPeople who are involved in cannabis investing are keeping a positive outlook towards the future. Many feel this year will be big for investors and have the potential to see a rise in marijuana stocks. The start of a new year comes with many challenges and opportunities. Much of the obstacles to overcome have to do with better reform measures for legal cannabis operators. What this means is during 2024 many hope to see the end of cannabis prohibition.If cannabis ref ...

NASDAQ | TSX: ACB EDMONTON, AB, Feb. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, is pleased to announce today that Simona King, a former executive of Bristol Myers-Squibb, a leading multinational pharmaceutical company, has been appointed as Chief Financial Officer of the Company, effective February 21, 2024. Ms. King brings over 25 years of progressive finance leadership experience, with deep ...

Top Marijuana Stocks For Investors 2024Investors are working on various strategies to see returns from their marijuana stock investments. As most who are active in the sector can see the upward momentum is not consistent. Much of the way cannabis stocks perform is based on volatility and other catalysts. For example, when there is news important enough to interest traders it often leads to a rise in trading. Still with a lot going on throughout the cannabis sector where is one to start when developing a tra ...

大麻行业投资风险 - 大麻行业投资者面临动荡局势，需要注意卖出的股票[1] Canopy Growth (CGC) 财务困境 - Canopy Growth (CGC) 股价急剧下跌，面临破产风险，财务状况堪忧[3][4] Aurora Cannabis (ACB) 股价下滑 - Aurora Cannabis (ACB) 面临诉讼和财务困境，股价和营收均大幅下滑，存在进一步下跌风险[6][7][8][9] MedMen (MMNFF) 财务困境 - MedMen (MMNFF) 面临财务困境，股价暴跌，营收下滑严重，公司前景不容乐观[10][11][12]

Aurora Cannabis - Aurora Cannabis在加拿大大麻市场遭遇供应过剩和获取零售许可证缓慢的问题[2] - Aurora Cannabis未能成功寻找资金雄厚的合作伙伴，通过发行新股票来实现增长，导致收入不稳定、持续亏损和股价表现糟糕[3] - Aurora Cannabis在医用大麻领域取得一定成功，但市场竞争激烈，且大麻饮料市场也面临竞争[5][6] - Aurora Cannabis承诺在2024年实现正的自由现金流，但由于市场挑战、缺乏稳定增长愿景，投资者应完全忽略该股票[7] Peloton Interactive - Peloton Interactive在疫情期间受欢迎，但随着健身房重新开放，公司业绩下滑，股价表现糟糕[8][9] - Peloton正试图转向订阅模式，虽然订阅收入有所增长，但公司仍面临来自竞争对手和健身房的竞争，难以实现完全复苏[10][11][12][13]